Study on the Efficacy and Safety of Tedizolid in Japanese Patients
<b>Background/Objective</b>: Tedizolid (TZD), an oxazolidinone, causes fewer adverse events than linezolid (LZD). However, studies on the long-term efficacy and safety of TZD, particularly in patients with hematological malignancies (HMs), remain limited. This study aimed to evaluate the...
Saved in:
| Main Authors: | Kazuhiro Ishikawa, Yasumasa Tsuda, Nobuyoshi Mori |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-12-01
|
| Series: | Antibiotics |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-6382/13/12/1237 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COMPARISON OF THE CLINICAL ACTIVITY OF TWO OXAZOLIDINONES – LINEZOLID AND TEDIZOLIDE: UNJUSTIFIED EXPECTATIONS
by: N. V. Dmitrieva, et al.
Published: (2018-11-01) -
Pharmacokinetic/pharmacodynamic analysis of tedizolid phosphate against Staphylococcus aureus and Streptococcus pneumoniae in children, adolescents, and adults by Monte Carlo simulation
by: Xiao-Chen Wei, et al.
Published: (2025-01-01) -
Current Problems of Infections Caused by MRSA and Ways to Address Them
by: S. K. Zyryanov, et al.
Published: (2020-05-01) -
Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center
by: Arun B Karanwal, et al.
Published: (2013-01-01) -
Prevalence of thrombocytopenia among patients with malaria in Ethiopia: a systematic review and metanalysis
by: Mikiyas Shemelis Achame, et al.
Published: (2025-02-01)